Stock AADI AADI BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Aadi Bioscience, Inc.

Equities

AADI

US00032Q1040

Real-time Estimate Cboe BZX
Other stock markets
 03:46:57 2024-04-29 pm EDT 		5-day change 1st Jan Change
1.815 USD +3.71% Intraday chart for Aadi Bioscience, Inc. -4.21% -9.90%
Mar. 13 Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024
Mar. 13 Earnings Flash (AADI) AADI BIOSCIENCE Posts Q4 Revenue $6.3M MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research Annual Meeting
AQ
Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)
PR
Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update
PR
Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update
PR
Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa
PR
Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference
PR
Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations
PR
Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update
PR
Aadi Bioscience to Participate in Jefferies London Healthcare Conference
PR
Aadi Bioscience to Report Third Quarter 2023 Results and Operational Update
PR
Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Cancer Society (IGCS) 2023 Annual Global Meeting
PR
Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
PR
Aadi Bioscience : Corporate Presentation
PU
Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award under Nasdaq Listing Rule 5635 (4)
AQ
Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)
PR
Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer
PR
Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
PR
Aadi Bioscience : Corporate Presentation
PU
Aadi Bioscience to Participate at Upcoming Investor Conferences
PR
Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate Update
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AADI Stock
  4. News Aadi Bioscience, Inc.
  5. Press Releases